CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $214,000 | +67.2% | 92,010 | +104.9% | 0.01% | +85.7% |
| Q4 2017 | $128,000 | +26.7% | 44,901 | +27.3% | 0.01% | +16.7% |
| Q3 2017 | $101,000 | +124.4% | 35,278 | +175.5% | 0.01% | +50.0% |
| Q4 2016 | $45,000 | -58.3% | 12,807 | -51.9% | 0.00% | -42.9% |
| Q3 2016 | $108,000 | +18.7% | 26,631 | +28.9% | 0.01% | +40.0% |
| Q2 2016 | $91,000 | -46.8% | 20,653 | +89.7% | 0.01% | -50.0% |
| Q4 2015 | $171,000 | -61.0% | 10,886 | -73.8% | 0.01% | -54.5% |
| Q3 2015 | $438,000 | +84.8% | 41,513 | +341.1% | 0.02% | +83.3% |
| Q2 2015 | $237,000 | -62.9% | 9,411 | -59.0% | 0.01% | -61.3% |
| Q1 2015 | $639,000 | +158.7% | 22,932 | +51.5% | 0.03% | +106.7% |
| Q2 2014 | $247,000 | – | 15,134 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |